When Wells W. was diagnosed with stage 4 lung cancer in 1998, doctors told him he had just 10 months to live. But Wells, a scientist by training, took charge of his care—researching treatments, getting second opinions, and joining a compassionate use trial for Iressa (gefitinib), a targeted therapy that matched his EGFR mutation. His tumors shrank enough for surgery, and he’s continued to live cancer-managed ever since.
Now 91, Wells has dedicated his life to lung cancer advocacy, co-founding GO2 for Lung Cancer and mentoring others facing the disease. His journey proves that even with a stage 4 diagnosis, hope, action, and long-term survival are possible. (Source: GO2 for Lung Cancer)
